<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811638</url>
  </required_header>
  <id_info>
    <org_study_id>Saglik Bilimleri University</org_study_id>
    <nct_id>NCT04811638</nct_id>
  </id_info>
  <brief_title>The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool</brief_title>
  <official_title>The Validity and Reliability of the Turkish Version of the Chelsea Critical Care Physical Assesment Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saglik Bilimleri Universitesi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Park Hospital Istanbul</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Saglik Bilimleri Universitesi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at providing an translation and cross-cultural adaptation of Chelsea&#xD;
      Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Survival has increased in the ICU due to technological developments , but physical disability&#xD;
      after discharge has become an important problem. İntensive Care Unit Acquired&#xD;
      Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons&#xD;
      for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use&#xD;
      of measurement tools to evaluate disabilities during stay and after discharge in intensive&#xD;
      care unit, is a subject that has been researched all over the world.. These measurement tools&#xD;
      provide; monitoring and evaluation during the ICU admission and assessment efficacy of&#xD;
      treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been&#xD;
      shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical&#xD;
      measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to&#xD;
      independence and consist of ten physical function parameters. This study is aimed at&#xD;
      providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical&#xD;
      Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a&#xD;
      pre-test of the Turkish version on 10 patients, a final revision, and a validation on a&#xD;
      sample of 40 İCU patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2021</start_date>
  <completion_date type="Anticipated">January 11, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 11, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chelsea Critical Care Physical Assesment Tools</measure>
    <time_frame>three days</time_frame>
    <description>The Chelsea critical care physical assessment (CPAx) is a measurement tool used to assess physical function in the ICU. The Chelsea critical care physical assessment (CPAx) tool is an outcome measure designed to assess 10 domains of physical ability: respiratory function, cough, bed mobility, supine to sitting on the edge of the bed, dynamic sitting, sit to stand, standing balance, transferring from bed to chair, stepping and grip strength.&#xD;
The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physical Function in Intensive Care Test</measure>
    <time_frame>three days</time_frame>
    <description>The PFIT is a test that measures function status of patients with a variety of conditions in the ICU. It includes 5 items: amount of assistance for sit-to-stand transfers, strength for shoulder flexion, strength for knee extension, marching in place, and an upper extremity endurance task of arm elevation to 90 degrees of shoulder flexion.&#xD;
PFIT used for criterion validity.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>ICU Patients</condition>
  <condition>ICU Acquired Weakness</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Validation of the Chelsea Critical Care Physical Assesment Tools</intervention_name>
    <description>The validation of the CPAX tools will focus on the validity of constructs, internal consistency reliability and test-retest reliability. PFIT used for criterion validity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICU patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Older than 18 years&#xD;
&#xD;
          -  Critical adult patients&#xD;
&#xD;
          -  Patients who were hospitalized for more than 48 hours in an ICU&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable fracture&#xD;
&#xD;
          -  Limb deformities and dysfunction&#xD;
&#xD;
          -  Myasthenia gravis&#xD;
&#xD;
          -  Neuromuscular dysfunction&#xD;
&#xD;
          -  Patients who diagnosed COVİD-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esra Pehlivan, Ass.Prof</last_name>
    <role>Study Director</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mehmet Burak Uyaroğlu, PT, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sümeyye Akcay, PT, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gamze Koyutürk, PT, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hakan Parlak, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Istinye University Bahcesehir Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kürsat Baydilli, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Saglik Bilimleri Universitesi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esra Pehlivan, Ass.Prof.</last_name>
    <phone>+90 505 852 79 13</phone>
    <email>esra.pehlivan@sbu.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehmet Burak Uyaroğlu, PT, MSc</last_name>
    <phone>+90 539 654 53 52</phone>
    <email>mburakuyaroglu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mehmet Burak Uyaroğlu</name>
      <address>
        <city>İ̇stanbul</city>
        <zip>34415</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Burak Uyaroğlu, PT, MSc</last_name>
      <phone>+90 539 654 53 52</phone>
      <email>mburakuyaroglu@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Esra Pehlivan, Ass. Prof.</last_name>
      <phone>+90 505 852 79 13</phone>
      <email>esra.pehlivan@sbu.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saglik Bilimleri Universitesi</investigator_affiliation>
    <investigator_full_name>Mehmet Burak Uyaroğlu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Physical Function</keyword>
  <keyword>Critical İll</keyword>
  <keyword>ICU Acquired Weakness</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

